{"gao_id": "GAO-21-22", "published": "2020-10-01T12:00:00Z", "released": "2020-10-01T08:00:00Z", "summary": "Prescription medications, if misused or overprescribed, can lead to dangerous drug interactions, abuse, overdose, or death. Prescription drug monitoring programs\u2014state-operated electronic databases that track patient prescriptions for opioids and other medications\u2014can help. Physicians said that access to these programs improved patient care and helped them prevent drug misuse and potentially dangerous drug prescribing. But drug monitoring programs aren't always accessible from within electronic health record...", "title": "Prescription Drug Monitoring Programs: Views on Usefulness and Challenges of Programs", "topics": ["Health care", "Patient care", "Prescription drugs", "Pharmacy", "Electronic health records", "Drug control", "Health Care", "Pharmacist", "Controlled substances", "Health care providers", "Physicians"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-21-22", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-21-22-highlights.pdf"}, {"title": "Full Report (37 pages)", "url": "https://www.gao.gov/assets/gao-21-22.pdf"}, {"title": "Accessible PDF (38 pages)", "url": "https://www.gao.gov/assets/720/710187.pdf"}]}